Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Positron emission tomography superior to standard evaluation tools in measuring treatment response

04.02.2008
Standard evaluation imaging missed 80 percent of responders

Positron Emission Tomography (PET) was much more sensitive and more accurate than conventional imaging methods in detecting response to treatment in sarcoma patients, according to a UCLA study that is among the first to directly compare PET to CT scanning.

The study has important implications for patients. If conventional imaging fails to detect treatment response, oncologists may discontinue therapies that in fact are working and study participants may be dismissed from clinical trials that are actually helping them. Conversely, if a patient is not responding, using PET scanning to evaluate response could help prevent them from undergoing toxic therapies that aren’t working.

The study, conducted by a multidiscplinary team of scientists at UCLA’s Jonsson Cancer Center, appears in the Feb. 1, 2008 issue of Clinical Cancer Research. Researchers found that standard size-based evaluation methods only identified 20 percent of responders, while PET was able to identify responders 100 percent of the time.

Current practice evaluates response to treatment using RECIST, or Response Evaluation Criteria in Solid Tumors. Patients are scanned using CT or MRI before and after treatment and the scans are then compared to determine if the tumor has decreased in size. If there is no change, the disease is considered stable. A partial response is tumor shrinkage of more than 30 percent, while a total response is tumor elimination.

“We knew from our considerable experience with neoadjuvant therapy (treatment before surgery) in sarcoma patients, that measuring tumor size correlated poorly with response,” said Dr. Fritz Eilber, an assistant professor of surgery, director of the Sarcoma Program at UCLA’s Jonsson Cancer Center and senior author of the study. “We have removed many tumors that have not changed in size with treatment or have even grown, but are completely dead on pathologic analysis. Just because the tumor doesn’t shrink doesn’t mean the treatment didn’t work.”

Eilber and his team of top scientists, including PET scan inventor Michael Phelps, wanted to find a better way to predict response so patients would not have to undergo unnecessary treatment or be removed from therapies that were working. Since operable sarcomas are treated before surgery with chemotherapy and radiation, it was the ideal cancer in which to compare PET scanning to CT.

CT and MRI scans provide anatomical pictures of the body, while PET images many different biochemical functions in real time, acting as a sort of molecular camera. Unlike CT and MRI, PET doesn’t just take a snapshot of body structures, it watches what the body is doing.

In this study, researchers measured the metabolic activity of the tumor, or how much sugar was being consumed in the cancer cells. Cancer cells, because they’re growing uncontrollably, use much more sugar than do normal cells. Using a specific PET probe that measures sugar metabolism, researchers could determine whether the cancer cells in the tumor were still alive and dividing after chemotherapy and radiation, Eilber said.

Researchers used a PET/CT scanner in the study, a technologic advance that combines the imaging modalities in one machine. The combined scanner allowed researchers to directly compare the before and after treatment scans for both tumor size and metabolic activity.

“PET was much more sensitive in picking up response than size-based RECIST,” Eilber said. “RECIST missed a large percentage of patients that actually had a response. PET picked up all of the responders.”

The study also has important implications for long-term patient follow-up, Eilber said. PET scanning quickly tells doctors how much of the tumor is dead. The amount of tumor that dies during treatment correlates with patient outcomes. If a large amount of the tumor is killed during treatment, sarcoma patients experience increased survival and lower recurrence rates.

This form of monitoring response to treatment also will be important in evaluating patients whose cancers have spread throughout the body, Eilber said.

“Evaluating biologic responses to therapy is the future of cancer imaging,” he said.

Eilber and his team already are working to confirm their results in a larger study and are testing new metabolic tracers to assess treatment response.

The study represented a true multidisciplinary effort, Eilber said. Experts from surgery, medical oncology, radiology, pathology, orthopedics, nuclear medicine and biostatistics comprised the research team.

Kim Irwin | EurekAlert!
Further information:
http://www.mednet.ucla.edu

More articles from Studies and Analyses:

nachricht New study: How does Europe become a leading player for software and IT services?
03.04.2017 | Fraunhofer-Institut für System- und Innovationsforschung (ISI)

nachricht Reusable carbon nanotubes could be the water filter of the future, says RIT study
30.03.2017 | Rochester Institute of Technology

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Making lightweight construction suitable for series production

More and more automobile companies are focusing on body parts made of carbon fiber reinforced plastics (CFRP). However, manufacturing and repair costs must be further reduced in order to make CFRP more economical in use. Together with the Volkswagen AG and five other partners in the project HolQueSt 3D, the Laser Zentrum Hannover e.V. (LZH) has developed laser processes for the automatic trimming, drilling and repair of three-dimensional components.

Automated manufacturing processes are the basis for ultimately establishing the series production of CFRP components. In the project HolQueSt 3D, the LZH has...

Im Focus: Wonder material? Novel nanotube structure strengthens thin films for flexible electronics

Reflecting the structure of composites found in nature and the ancient world, researchers at the University of Illinois at Urbana-Champaign have synthesized thin carbon nanotube (CNT) textiles that exhibit both high electrical conductivity and a level of toughness that is about fifty times higher than copper films, currently used in electronics.

"The structural robustness of thin metal films has significant importance for the reliable operation of smart skin and flexible electronics including...

Im Focus: Deep inside Galaxy M87

The nearby, giant radio galaxy M87 hosts a supermassive black hole (BH) and is well-known for its bright jet dominating the spectrum over ten orders of magnitude in frequency. Due to its proximity, jet prominence, and the large black hole mass, M87 is the best laboratory for investigating the formation, acceleration, and collimation of relativistic jets. A research team led by Silke Britzen from the Max Planck Institute for Radio Astronomy in Bonn, Germany, has found strong indication for turbulent processes connecting the accretion disk and the jet of that galaxy providing insights into the longstanding problem of the origin of astrophysical jets.

Supermassive black holes form some of the most enigmatic phenomena in astrophysics. Their enormous energy output is supposed to be generated by the...

Im Focus: A Quantum Low Pass for Photons

Physicists in Garching observe novel quantum effect that limits the number of emitted photons.

The probability to find a certain number of photons inside a laser pulse usually corresponds to a classical distribution of independent events, the so-called...

Im Focus: Microprocessors based on a layer of just three atoms

Microprocessors based on atomically thin materials hold the promise of the evolution of traditional processors as well as new applications in the field of flexible electronics. Now, a TU Wien research team led by Thomas Müller has made a breakthrough in this field as part of an ongoing research project.

Two-dimensional materials, or 2D materials for short, are extremely versatile, although – or often more precisely because – they are made up of just one or a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Fighting drug resistant tuberculosis – InfectoGnostics meets MYCO-NET² partners in Peru

28.04.2017 | Event News

Expert meeting “Health Business Connect” will connect international medical technology companies

20.04.2017 | Event News

Wenn der Computer das Gehirn austrickst

18.04.2017 | Event News

 
Latest News

Wireless power can drive tiny electronic devices in the GI tract

28.04.2017 | Medical Engineering

Ice cave in Transylvania yields window into region's past

28.04.2017 | Earth Sciences

Nose2Brain – Better Therapy for Multiple Sclerosis

28.04.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>